Digital Pathology Solutions

Contact us

For business enquiries, contact our team by email. Online form delivery is currently unavailable.

Digital Pathology Solutions handles business enquiries. This website has no accounts or newsletter subscription. Form entries remain in your browser; online delivery is not connected.

For information about website data, email enquiries and your rights, read our Privacy Policy.

Do not include patient information, passwords or confidential third-party material. Reading this notice does not subscribe you to marketing.

Frequently asked questions

Everything you need to know about our models, solutions, deployment, and getting in touch.

We build software for digital pathology workflows, including image review, biomarker measurement, and research evaluation. Product capabilities and deployment options depend on the relevant scope and documentation.

Available models and biomarkers depend on the product documentation and intended use. Ask the team for the current scope, supported inputs, and evaluation process for your workflow.

Clinical and research offerings can have different intended uses, workflows, documentation, and evaluation requirements. The applicable scope is confirmed for each engagement.

The platform is designed around documented workflows, reviewable outputs, and specialist oversight. Differences between products should be assessed against the relevant documentation and local workflow.

Deployment and any system interfaces are scoped to the product, service configuration, and host requirements. Roll-out can include assessment, testing, and supervised evaluation before routine use where appropriate.

The effect on an existing workflow depends on the product and configuration. Outputs are intended to support review where documented, and qualified professionals remain responsible for applicable decisions.

Privacy and data-handling arrangements depend on the service scope and configuration. The applicable documentation and project agreement define processing, access, retention, and deployment details.

Evaluation methods depend on the product and intended use. Where applicable, project scoping can define representative data, review criteria, local testing, and documentation before routine use.

Regulatory status depends on the specific product, intended use, documentation, and region. The team can explain the current documented scope for your jurisdiction.

Research and biopharma enquiries can cover biomarker workflows, evaluation, and study support. Scope, evidence, and deliverables are agreed for each project.

Email our team with your business requirements and scanner setup to discuss an appropriately scoped pilot. Do not send patient information or slides through this website or ordinary email; any evaluation materials require separately agreed secure arrangements.

Our team will direct your email enquiry to the appropriate clinical, research, services or general contact.

Still have questions?

We're happy to help.

Email our team to discuss your question with the appropriate specialist.

Back to the form